رجوع
نطاق اليوم
KWD 21.58
KWD 22.25
نطاق 52 أسبوعًا
KWD 11.86
KWD 31.77
حجم التداول
753,317
متوسط 50 يوم / 200 يوم
KWD 25.67
/
KWD 21.49
الإغلاق السابق
KWD 22.29
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (627 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -167.8 | 0.3 |
| P/B | 14.3 | 2.9 |
| ROE % | -9.3 | 3.7 |
| Net Margin % | -4.3 | 3.8 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.0 | 0.2 |
السعر المستهدف للمحللين
Hold
KWD 33.330
+52.7%
Low: KWD 29.000
High: KWD 37.000
مكرر الربحية المستقبلي
65.9
ربحية السهم المستقبلية
KWD 0.339
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
500 M
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2030 |
KWD 3.058
KWD 2.986 – KWD 3.216
|
1.1 B | 2 |
| FY2029 |
KWD 2.630
KWD 2.568 – KWD 2.766
|
920 M | 4 |
| FY2028 |
KWD 1.994
KWD 1.435 – KWD 2.788
|
780 M | 6 |
النقاط الرئيسية
Debt/Equity of 0.03 — conservative balance sheet
Negative free cash flow of -6.31M
Capital efficient — spends only 0.18% of revenue on capex
النمو
Revenue Growth (5Y)
N/A
Revenue (1Y)91.34%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
الجودة
Return on Equity
-9.30%
ROIC-4.68%
Net Margin-4.29%
Op. Margin-3.25%
الأمان
Debt / Equity
0.03
Current Ratio3.17
Interest Coverage-1.01
التقييم
P/E Ratio
-167.75
P/B Ratio14.29
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 91.34% | Revenue Growth (3Y) | 151.18% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 376.07M | Net Income (TTM) | -16.14M |
| ROE | -9.30% | ROA | -3.73% |
| Gross Margin | 90.24% | Operating Margin | -3.25% |
| Net Margin | -4.29% | Free Cash Flow (TTM) | -6.31M |
| ROIC | -4.68% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.03 | Current Ratio | 3.17 |
| Interest Coverage | -1.01 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -167.75 | P/B Ratio | 14.29 |
| P/S Ratio | 7.20 | PEG Ratio | 2.58 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 2.71B | Enterprise Value | 2.67B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 376.07M | 196.54M | 59.61M | 3.69M | 0.0 |
| Net Income | -16.14M | -140.04M | -262.14M | -311.46M | -206.36M |
| EPS (Diluted) | -0.13 | -1.16 | -3.78 | -5.66 | -4.17 |
| Gross Profit | 339.38M | 177.41M | 54.62M | 2.93M | -763,000.0 |
| Operating Income | -12.23M | -128.40M | -241.10M | -301.63M | -206.53M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 432.97M | 348.89M | 341.37M | 449.27M | 408.15M |
| Total Liabilities | 243.49M | 191.35M | 252.70M | 239.69M | 110.48M |
| Shareholders' Equity | 189.48M | 157.54M | 88.67M | 209.58M | 297.68M |
| Total Debt | 6.27M | 110.59M | 205.92M | 202.54M | 77.56M |
| Cash & Equivalents | 42.91M | 71.34M | 88.40M | 53.64M | 97.99M |
| Current Assets | 411.23M | 335.82M | 330.43M | 437.41M | 402.77M |
| Current Liabilities | 129.84M | 81.01M | 46.67M | 37.81M | 33.33M |